1. Implementation of Novel Molecular Biomarkers for Non-small Cell Lung Cancer in the Netherlands: How to Deal With Increasing Complexity

   van den Broek, D., Hiltermann, T. J. N., Biesma, B., Dinjens, W. N. M., 't Hart, N. A., Hinrichs, J. W. J., Leers, M. P. G., Monkhorst, K., van Oosterhout, M., Scharnhorst, V., Schuuring, E., Speel, E-J. M., van den Heuvel, M. M., van Schaik, R. H. N., von der Thüsen, J., Willems, S. M., de Visser, L. & Ligtenberg, M. J. L., 2019, In : Frontiers in Oncology. 9, p. 1521

   Research output: Contribution to journal › Review article › Academic › peer-review

2. Treatment goals and changes over time in older patients with non-curable cancer

   Stegmann, M. E., Brandenbarg, D., Reyners, A. K. L., van Geffen, W. H., Hiltermann, T. J. N. & Berendsen, A. J., 22-Dec-2020, In : Supportive Care in Cancer. 8 p.

   Research output: Contribution to journal › Article › Academic › peer-review

3. Dutch Oncology COVID-19 consortium: Outcome of COVID-19 in patients with cancer in a nationwide cohort study

   DOCC Investigators, de Joode, K., Tol, J., Westgeest, H. M., Beerepoot, L. V., van den Berkmortel, F. W. P. J., Mutsaers, P. G. N. J., van Diemen, N. G. J., Visser, O. J., Oomen-de Hoop, E., Bloemendal, H. J., van Laarhoven, H. W. M., Hendriks, L. E. L., Haanen, J. B. A. G., de Vries, E. G. E., Dingemans, A. M. C. & van der Veldt, A. A. M., Dec-2020, In : European Journal of Cancer. 141, p. 171-184 14 p.

   Research output: Contribution to journal › Article › Academic › peer-review

4. The clinical effect of concurrent oncogenic gene mutations in BRAF p.(V600E)-mutated NSCLC treated with dabrafenib and trametinib

   Meng, P., Koopman, B., Kok, K., ter Elst, A., Schuuring, E., van Kempen, L. C., Timens, W., Hiltermann, T. J. N., Groen, H. J. M., van den Berg, A. & van der Wekken, A. J., Sep-2020, In : Annals of Oncology. 31, p. S1106-S1106 1 p.

   Research output: Contribution to journal › Meeting Abstract › Academic

5. An All-In-One Transcriptome-Based Assay to Identify Therapy-Guiding Genomic Aberrations in Nonsmall Cell Lung Cancer Patients

   Wei, J., Rybczynska, A. A., Meng, P., Terpstra, M., Saber, A., Sietzema, J., Timens, W., Schuuring, E., Hiltermann, T. J. N., Groen, H. J. M., van der Wekken, A. J., van den Berg, A. & Kok, K., Oct-2020, In : Cancers. 12, 10, p. 1-17 18 p., 2843.

   Research output: Contribution to journal › Article › Academic › peer-review

View all (102) »

1. Treatment, pharmacological and non-pharmacological of lung cancer

   Jeroen Hiltermann (Invited speaker)

   22-Jun-2018

   Activity: Talk or presentation › Professional

2. Behandeling van Immunotherapie gerelateerde bijwerkingen met nadruk op de immuun gerelateerde pneumonitis

   Jeroen Hiltermann (Invited speaker)

   18-Sep-2018

   Activity: Talk or presentation › Professional

3. WCLC Toronto 2019

   Jeroen Hiltermann (Participant)

   22-Sep-2018 → 29-Sep-2018

   Activity: Participating in or organising an event › Participation in conference › Professional

View all (27) »